首頁 > 市場調查報告書 > 醫療設備

生物材料

市場調查報告書

商品編碼

1736792

全球醫用塑膠市場規模（按產品類型、製程技術、應用、區域範圍和預測）

Global Medical Plastics Market Size By Product Type (PE, PP), By Process Technology (Extrusion, Injection Molding), By Application (Medical Device Packaging, Medical Components), By Geographic Scope And Forecast

出版日期: 2025年05月07日 | 出版商:

Verified Market Research | 英文 202 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

醫用塑膠市場規模及預測

2024 年醫用塑膠市場規模為 267.8 億美元，預計到 2032 年將達到 446.6 億美元，2026 年至 2032 年的複合年成長率為 6.60%。

醫用塑膠是現代醫療保健的重要組成部分，促進了各種醫療設備和器械的開發和使用。

這些特種聚合物具有生物相容性、耐久性和耐滅菌性等優異性能，非常適合醫療領域的應用。

醫用級塑膠經過精心設計，與人體組織和體液相容，最大限度地降低了副作用的風險。

醫用塑膠具有優異的耐用性，甚至可以承受滅菌過程，從而延長醫療設備的使用壽命。

醫用塑膠具有高度可自訂性，可以製造滿足特定要求的設備，包括靈活性、強度和透明度。

與其他材料相比，醫用級塑膠是一種經濟高效的選擇，尤其是對於一次性醫療器材而言。

全球醫用塑膠市場動態

影響全球醫用塑膠市場的關鍵市場動態是：

關鍵市場促進因素

一次性醫療設備需求不斷成長：感染疾病的上升正在推動一次性醫療設備的需求。例如，2024年2月12日，美國碧迪公司（BD）宣布投資12億美元擴建其一次性醫療醫療設備生產設施，以滿足全球一次性醫療產品激增的需求。

老年醫療設備應用領域不斷拓展：老齡人口的成長推動了各種醫療保健應用領域對醫用塑膠的需求。根據聯合國報告，2023年，全球65歲以上人口將增加3.5%。例如，科思創於2024年3月5日推出了一系列專為老年醫療設備設計的全新生物相容性聚合物，以滿足老齡化社會的獨特需求。

微創手術日益普及：向微創手術的轉變正在推動醫用塑膠的應用。例如，贏創工業集團於2024年1月20日推出了一種用於腹腔鏡手術器械的新型高性能聚合物，以提高其耐用性並縮短手術時間。

更加重視感染控制：人們對醫療相關感染的擔憂日益加劇，這推動了對抗菌塑膠的需求。美國疾病管制與預防中心 (CDC) 報告稱，到 2023 年，使用抗菌塑膠的醫療機構的醫療相關感染率將下降 22%。

主要問題

監管障礙阻礙市場准入：醫療設備產業必須遵守嚴格的法規，以確保其安全性和有效性。遵守這些法規的過程複雜且耗時，阻礙了新型醫用塑膠產品進入市場。

替代材料的競爭阻礙市場成長：醫用塑膠面臨來自金屬和陶瓷等其他材料的競爭，這些材料可能適用於某些應用。這些替代材料可能在強度、耐用性、生物相容性等方面具有優勢，這限制了醫用塑膠的市場佔有率。

創新挑戰：材料科學和製造流程的發展對於開發創新醫用塑膠至關重要，但技術限制可能會阻礙具有改進性能和應用的新材料的創造。

供應鏈中斷阻礙生產：全球醫用塑膠供應鏈容易受到自然災害、地緣政治事件、景氣衰退等因素造成的中斷的影響。這些中斷可能導致原料短缺、成本上升和生產延遲。

主要趨勢

藥物輸送系統應用不斷擴展：藥物輸送技術的進步正在推動醫用塑膠的創新。 2023年，美國食品藥物管理局（FDA）核准了53種採用先進聚合物的新型藥物輸送裝置。例如，2024年2月28日，索爾維宣佈在可植入藥物釋放型聚合物研發方面取得突破，這可能會徹底改變慢性病的長期用藥方式。

家庭醫療保健設備需求不斷成長：家庭護理的日益成長趨勢推動了對耐用、易用的醫用級塑膠的需求。根據美國居家照護和臨終關懷協會的數據，美國家庭醫療保健市場到2023年將成長8.5%。

更重視永續性：人們對環境影響的日益關注，正推動生物基和可回收醫用塑膠的創新。例如，杜邦公司於2024年1月5日宣布，到2030年，其50%的醫用塑膠將由可再生資源生產，並將率先推出一系列全新的生物基手術器械手柄。

3D列印應用不斷擴展：3D列印在醫療保健領域的日益普及，推動了特種醫用塑膠的需求。美國食品藥物管理局（FDA）在2023年核准了35種3D列印醫療設備，與前一年同期比較增加了25%。例如，2024年4月10日，Stratasys Ltd.宣布推出一系列用於3D列印義肢和手術導板的新型生物相容性樹脂，增強了患者照護的客製化能力。

Rising Demand for Disposable Medical Devices: The increasing prevalence of infectious diseases is fueling the need for disposable medical devices. For instance, in February 12, 2024, Becton, Dickinson and Company (BD) announced a $1.2 billion investment to expand its disposable medical device production facilities, aiming to meet the surging global demand for single-use medical products.

Expanding Applications for Geriatric Care Devices: The expanding elderly demographic is driving demand for medical plastics in various healthcare applications. The UN reported that the global population aged 65 and above grew by 3.5% in 2023. For instance, in March 5, 2024, Covestro launched a new line of biocompatible polymers specifically designed for geriatric care devices, addressing the unique needs of the aging population.

Increasing Adoption of Minimally Invasive Surgeries: The shift towards less invasive surgical procedures is boosting the use of medical plastics. For instance, in January 20, 2024, Evonik Industries introduced a new high-performance polymer for laparoscopic surgical instruments, enhancing durability and reducing procedure times.

Rising Focus on Infection Control: Growing concerns about healthcare-associated infections are propelling the demand for antimicrobial plastics. The CDC reported a 22% reduction in healthcare-associated infections in facilities using antimicrobial plastics in 2023.

Key Challenges:

Regulatory Hurdles Hindering Market Entry: The medical device industry is subject to stringent regulations to ensure safety and efficacy. Compliance with these regulations can be complex and time-consuming, hindering market entry for new medical plastic products.

Competition from Alternative Materials Hampering Market Growth: Medical plastics face competition from other materials, such as metals and ceramics, which may be suitable for certain applications. These alternative materials can offer advantages in terms of strength, durability, or biocompatibility, limiting the market share of medical plastics.

Technological Limitations Challenging Innovation: Advancements in materials science and manufacturing processes are essential for the development of innovative medical plastics. However, limitations in technology can hinder the creation of new materials with improved properties and applications.

Supply Chain Disruptions Obstructing Production: The global supply chain for medical plastics can be vulnerable to disruptions, such as those caused by natural disasters, geopolitical events, or economic downturns. These disruptions can lead to shortages of raw materials, increased costs, and delays in production.

Key Trends

Expanding Applications in Drug Delivery Systems: The evolving field of drug delivery is fueling innovations in medical plastics. The FDA approved 53 new drug delivery devices utilizing advanced polymers in 2023. For instance, in February 28, 2024, Solvay announced a breakthrough in its development of implantable drug-eluting polymers, potentially revolutionizing long-term medication administration for chronic conditions.

Increasing Demand for Home Healthcare Devices: The growing trend of home-based care is driving the need for durable, user-friendly medical plastics. The U.S. Home Healthcare Market grew by 8.5% in 2023, according to the National Association for Home Care & Hospice.

Rising Emphasis on Sustainability: The growing focus on environmental impact is fueling innovations in bio-based and recyclable medical plastics. For instance, in January 5, 2024, DuPont announced its commitment to making 50% of its medical-grade plastics from renewable resources by 2030, starting with a new line of bio-based surgical instrument handles.

Expanding 3D Printing Applications: The increasing use of 3D printing in healthcare is driving demand for specialized medical plastics. The FDA cleared 35 3D-printed medical devices in 2023, a 25% increase from the previous year. For instance, in April 10, 2024, Stratasys Ltd. unveiled a new range of biocompatible resins for 3D-printed prosthetics and surgical guides, enhancing customization capabilities in patient care.

Global Medical Plastics Market Regional Analysis

Here is a more detailed regional analysis of the global medical plastics market:

North America:

North America is dominating the global medical plastics market, driven by advanced healthcare infrastructure and continuous technological innovations.

According to the U.S. Food and Drug Administration, the use of medical-grade plastics in approved devices increased by 18% in 2023 compared to the previous year.

For instance, in March 2, 2024, when Dow Chemical Company announced a $500 million investment in its Michigan facilities to expand production of high-performance medical plastics, focusing on materials for drug delivery systems and diagnostic equipment.

The region's market leadership is also supported by stringent regulations and a growing emphasis on patient safety.

Health Canada reported that 72% of newly registered medical devices in 2023 incorporated advanced polymers, highlighting the shift towards more durable and biocompatible materials.

For instance, in April 8, 2024, 3M Healthcare unveiled a new line of antimicrobial medical plastics, developed in collaboration with leading U.S. hospitals to combat healthcare-associated infections.

This innovation, coupled with the region's robust research and development capabilities, continues to solidify North America's position at the forefront of the global medical plastics market.

Europe:

The European region is projected to experience a rapid CAGR growth during the forecast period, driven by stringent regulations promoting safety and sustainability in healthcare.

According to the European Commission, the use of advanced medical plastics in healthcare facilities increased by 18% in 2023, with a particular focus on antimicrobial and eco-friendly materials.

This trend was further accelerated on March 8, 2024, when Borealis AG, a leading provider of innovative plastics solutions, announced a €200 million investment in its medical-grade polymer production facilities across Europe, aiming to meet the growing demand for high-performance, sustainable medical plastics.

Europe's market expansion is also fueled by technological advancements and an aging population requiring more medical interventions.

Eurostat reported that the proportion of the EU population aged 65 and over reached 20.8% in 2023, driving demand for specialized medical devices.

For instance, in February 15, 2024, Evonik Industries unveiled a new line of bio-based polymers for orthopedic implants, developed in collaboration with leading European research institutions. This innovation, coupled with the European Medicines Agency's approval of 28 new drug-device combination products utilizing advanced polymers in 2023, underscores the region's potential for continued rapid growth in the medical plastics market.

Global Medical Plastics Market: Segmentation Analysis

The Global Medical Plastics Market is segmented based on Product Type, Process Technology, Application, and Geography.

Medical Plastics Market, By Product Type

Polyethylene (PE)
Polypropylene (PP)
Polycarbonate (PC)
Others

Based on Product Type, the Global Medical Plastics Market is bifurcated into Polyethylene (PE), Polypropylene (PP), Polycarbonate (PC), Others. The polyethylene (PE) segment is dominating the medical plastics market, driven by its versatility, biocompatibility, and cost-effectiveness. However, the polypropylene (PP) segment is experiencing rapid growth, fueled by its superior mechanical properties, such as higher melting point and rigidity, making it suitable for a wider range of medical applications.

Medical Plastics Market, By Process Technology

Extrusion
Injection Molding
Blow Molding
Others

Based on Process Technology, the Global Medical Plastics Market is bifurcated into Extrusion, Injection Molding, Blow Molding, Others. The extrusion segment is currently dominating the medical plastics market, driven by its versatility and ability to produce a wide range of products, such as tubes, catheters, and packaging materials. However, the injection molding segment is experiencing rapid growth, as it allows for the production of more complex and precise medical devices, including syringes, diagnostic kits, and surgical instruments.

Medical Plastics Market, By Application

Medical Device Packaging
Medical Components
Orthopedic Implant Packaging
Orthopedic Soft Goods
Others

Based on Application, the Global Medical Plastics Market is bifurcated into Medical Device Packaging, Medical Components, Orthopedic Implant Packaging, Orthopedic Soft Goods, Others. The medical device packaging segment is currently dominating the medical plastics market, driven by the increasing demand for safe and effective packaging solutions for a wide range of medical devices. However, the orthopedic soft goods segment is experiencing rapid growth, fueled by the rising demand for disposable medical products, such as surgical gowns, drapes, and masks.

Medical Plastics Market, By Geography

North America
Europe
Asia Pacific
Rest of the world

Based on Geography, the Global Medical Plastics Market is classified into North America, Europe, Asia Pacific, and the Rest of the world. North America is dominating the global medical plastics market, driven by advanced healthcare infrastructure and continuous technological innovations. However, the European region is projected to experience a rapid CAGR growth during the forecast period, driven by stringent regulations promoting safety and sustainability in healthcare.

Key Players

The "Global Medical Plastics Market" study report will provide valuable insight with an emphasis on the global market. The major players in the market are Rochling SE & Co. KG; Nolato AB; Saint-Gobain; SABIC; Orthoplastics Ltd; Eastman Chemical Company; Celanese Corporation; Dow, Inc.; Tekni-Plex, Inc.; Solvay S.A.; HMC Polymers Company Limited.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with its product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

Global Medical Plastics Market Key Developments

In February 2023, Cleanse Corporation has strategically acquired DuPont's mobility and mobility business for a significant sum of USD 11.00 billion, expanding its global reach and bolstering its offerings within the environmental sector, particularly in sustainable transportation.
In June 2023, SABIC has acquired Clariant's stake in Scientific Design, a renowned catalysis leader, strengthening its non-cyclical, technology-driven business and solidifying its position as a global specialist in the field.

1 INTRODUCTION OF GLOBAL MEDICAL PLASTICS MARKET

1.1 Overview of the Market
1.2 Scope of Report
1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

3.1 Data Mining
3.2 Validation
3.3 Primary Interviews
3.4 List of Data Sources

4 GLOBAL MEDICAL PLASTICS MARKET OUTLOOK

4.1 Overview
4.2 Market Dynamics
- 4.2.1 Drivers
- 4.2.2 Restraints
- 4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis

5 GLOBAL MEDICAL PLASTICS MARKET, BY PRODUCT TYPE

5.1 Overview
5.2 Polyethylene (PE)
5.3 Polypropylene (PP)
5.4 Polycarbonate (PC)
5.5 Others

6 GLOBAL MEDICAL PLASTICS MARKET, BY PROCESS TECHNOLOGY

6.1 Overview
6.2 Extrusion
6.3 Injection Molding
6.4 Blow Molding
6.5 Others

7. Medical Plastics Market, By Application

7.1 Medical Device Packaging
7.2 Medical Components
7.3 Orthopedic Implant Packaging
7.4 Orthopedic Soft Goods
7.5 Others

8 GLOBAL MEDICAL PLASTICS MARKET, BY GEOGRAPHY

8.1 Overview
8.2 North America
- 8.2.1 U.S.
- 8.2.2 Canada
- 8.2.3 Mexico
8.3 Europe
- 8.3.1 Germany
- 8.3.2 U.K.
- 8.3.3 France
- 8.3.4 Rest of Europe
8.4 Asia Pacific
- 8.4.1 China
- 8.4.2 Japan
- 8.4.3 India
- 8.4.4 Rest of Asia Pacific
8.5 Rest of the World
- 8.5.1 Latin America
- 8.5.2 Middle East Africa

9 GLOBAL MEDICAL PLASTICS MARKET COMPETITIVE LANDSCAPE

9.1 Overview
9.2 Company Market Ranking
9.3 Key Development Strategies

10 COMPANY PROFILES

10.1 EASTMAN CHEMICAL COMPANY
- 10.1.1 Overview
- 10.1.2 Financial Performance
- 10.1.3 Product Outlook
- 10.1.4 Key Developments
10.2 CELANESE CORPORATION
- 10.2.1 Overview
- 10.2.2 Financial Performance
- 10.2.3 Product Outlook
- 10.2.4 Key Developments
10.3 COVESTRO AG
- 10.3.1 Overview
- 10.3.2 Financial Performance
- 10.3.3 Product Outlook
- 10.3.4 Key Developments
10.4 SOLVAY
- 10.4.1 Overview
- 10.4.2 Financial Performance
- 10.4.3 Product Outlook
- 10.4.4 Key Developments
10.5 THE LUBRIZOL CORPORATION
- 10.5.1 Overview
- 10.5.2 Financial Performance
- 10.5.3 Product Outlook
- 10.5.4 Key Developments
10.6 EVONIK INDUSTRIES AG
- 10.6.1 Overview
- 10.6.2 Financial Performance
- 10.6.3 Product Outlook
- 10.6.4 Key Developments
10.7 SAINT-GOBAIN PERFORMANCE PLASTICS
- 10.7.1 Overview
- 10.7.2 Financial Performance
- 10.7.3 Product Outlook
- 10.7.4 Key Developments
10.8 TRINSEO
- 10.8.1 Overview
- 10.8.2 Financial Performance
- 10.8.3 Product Outlook
- 10.8.4 Key Developments
10.10 ENSINGER
- 10.10.1 Overview
- 10.10.2 Financial Performance
- 10.10.3 Product Outlook
- 10.10.4 Key Developments
10.10 TEKNI-PLEX
- 9.10.1 Overview
- 9.10.2 Financial Performance
- 9.10.3 Product Outlook
- 9.10.4 Key Developments